CompoAtlas

Améa Camomille C

Natural health product licensed in Canada

Licence holder
les Laboratoires Améa Ltée
NPN or DIN-HM
80048616
Status
Active licence
Licence date
25 February 2014
Revision date
Not provided
Form
Huile
Application type
Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Matricaria chamomilla

Source : Matricaria chamomilla, fleur

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 10 g

2 %

Non-medicinal ingredients

Huile de graine de cannabis sativa

PopulationAgeQuantity per servingFrequency
Adolescentesminimum: 9 years ; maximum: 13 yearsNot specifiedNot specified
Enfantsminimum: 4 years ; maximum: 9 yearsNot specifiedNot specified
Adultes et adolescentsminimum: 13 yearsNot specifiedNot specified

Uses authorised in Canada

Utilisée en phytothérapie/herboristerie pour aider à soulager les inflammations et/ou irritations mineures de la peau

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80048616

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line